Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey

Por Nappi, R. E., Palacios, S., Panay, N., Particco, M., Krychman, M. L.
Publicado no Climacteric (2016)

Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding

Por Zara, F, Nappi, R, Brerra, R, Migliavacca, R, Maserati, R, Spinillo, A
Publicado em 2004

Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in...

Por Coccini, T, Randine, G, Candura, S M, Nappi, R E, Prockop, L D, Manzo, L
Publicado em 2000

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy

Por Bruyniks, N., Nappi, R. E., Castelo-Branco, C., de Villiers, T. J., Simon, J.
Publicado no Climacteric (2016)

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

Por Nappi, R. E., Panay, N., Bruyniks, N., Castelo-Branco, C., De Villiers, T. J., Simon, J. A.
Publicado no Climacteric (2015)